Jeanne K. Mason - 01 Mar 2024 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role
EVP, Chief HR Officer
Signature
/s/ Ellen K. Bradford, as attorney in-fact for Jeanne K. Mason
Issuer symbol
BAX
Transactions as of
01 Mar 2024
Net transactions value
-$261,331
Form type
4
Filing time
05 Mar 2024, 16:15:16 UTC
Previous filing
14 Feb 2024
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BAX Common Stock, $1 par value Options Exercise $2,397,019 +64,488 +45% $37.17 206,778 01 Mar 2024 Direct F1
transaction BAX Common Stock, $1 par value Sale $2,618,858 -64,488 -31% $40.61 142,290 01 Mar 2024 Direct F2
transaction BAX Common Stock, $1 par value Tax liability $39,493 -963 -0.68% $41.01 141,326 01 Mar 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BAX Stock Option (Right to Buy) Options Exercise $0 -64,488 -100% $0.000000* 0 01 Mar 2024 Common Stock, $1 par value 64,488 $37.17 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Ms. Mason on September 6, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Ms. Mason which were scheduled to expire on March 4, 2024.
F2 Price reflects weighted average sales price. Range of prices for transactions are $40.28 through $40.93. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request.
F3 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 1, 2024 from the settlement of vested restricted stock units granted on March 1, 2023.
F4 The options became exercisable in three equal annual installments beginning on March 4, 2015, the first anniversary of the grant date.